NVDA
NVIDIA Corporation
NVDA has the edge over SRAD overall, supported by stronger valuation and stronger modeled upside.
SRAD
Sportradar Group AG
SRAD's outlook is improving, though it still trails on the overall score.
NVDA Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Strong | |
| Strong | |
| Strong |
NVDA's revenue, profitability, cash flow and balance sheet are all currently strong.
SRAD Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Stable | |
| Strong | |
| Strong |
SRAD's revenue, cash flow and balance sheet are currently healthy, and its profitability is stable.
NVDA PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 12x | $166 | — |
| Current | 21x | $166 | — |
| Cheap | 44x | $345 | +108% |
| Fair | 65x | $511 | +207% |
| Expensive | 93x | $734 | +342% |
Historical ranges are pointers, not guarantees.
NVDA has the edge over SRAD in the historical PE scenario, which offers more potential upside but is not a forecast.
SRAD PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 61x | $3.69 | -71% |
| Fair | 113x | $6.76 | -48% |
| Expensive | 209x | $12.53 | -2.9% |
| Current | 231x | $12.91 | — |
Historical ranges are pointers, not guarantees.
SRAD's PE is 231x, but its earnings don't support one, so it isn't a reliable read right now.
NVDA Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Strong growth | |
| Weakening | |
| Broad | |
| Moderate |
Analysts expect strong earnings and revenue growth for NVDA, but weaker profitability.
SRAD Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Strong growth | |
| Growth | |
| Improving | |
| Limited | |
| Low |
SRAD has the edge over NVDA on the outlook, with more favorable profitability expectations.
NVDA Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $13.77 | +74% |
| Q3 2026 | $7.91 | +125% |
| Q2 2026 | $6.53 | +111% |
| Q1 2026 | $4.90 | +67% |
| Q4 2025 | $4.03 | +59% |
| Q3 2025 | $3.51 | +65% |
| Q2 2025 | $3.10 | +81% |
| Q1 2025 | $2.94 | +147% |
| Q4 2024 | $2.54 | +234% |
NVDA has the edge over SRAD on earnings, with more consistent year-over-year improvement.
SRAD Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q2 2026 | $0.06 | -84% |
| Q1 2026 | $0.24 | +14% |
| Q4 2025 | $0.34 | +183% |
| Q3 2025 | $0.32 | +52% |
| Q2 2025 | $0.38 | +375% |
| Q1 2025 | $0.21 | +133% |
| Q4 2024 | $0.12 | +9.1% |
| Q3 2024 | $0.21 | +$0.30 |
SRAD's earnings per share have fallen from their peak: $0.06 over the past year, against $0.38 in mid-2025.
NVDA Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $96.2B | +106% |
| Q2 2026 | $81.6B | +85% |
| Q1 2026 | $68.1B | +73% |
| Q4 2025 | $57B | +62% |
| Q3 2025 | $46.7B | +56% |
| Q2 2025 | $44.1B | +69% |
| Q1 2025 | $39.3B | +78% |
| Q4 2024 | $35.1B | +94% |
NVDA has the edge over SRAD on sales, with stronger typical year-over-year growth.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 66% | +5.4 points |
| Q2 2026 | 66% | +17 points |
| Q1 2026 | 65% | +3.9 points |
| Q4 2025 | 63% | +0.8 points |
| Q3 2025 | 61% | -1.2 points |
| Q2 2025 | 49% | -16 points |
| Q1 2025 | 61% | -0.5 points |
| Q4 2024 | 62% | +4.9 points |
NVDA has the edge over SRAD on profitability, with a higher operating margin.
SRAD Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $426.7M | +21% |
| Q1 2026 | $391.3M | +13% |
| Q4 2025 | $406M | +19% |
| Q3 2025 | $324.4M | +14% |
| Q2 2025 | $353M | +14% |
| Q1 2025 | $345.7M | +17% |
| Q4 2024 | $341.1M | +22% |
| Q3 2024 | $283.5M | +27% |
SRAD's revenue has grown year over year every quarter since early 2021: $427M last quarter, up 21% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | 10% | +1.5 points |
| Q1 2026 | 7.3% | -0.1 points |
| Q4 2025 | 6.1% | -5.6 points |
| Q3 2025 | 16% | +1.1 points |
| Q2 2025 | 8.8% | -0.8 points |
| Q1 2025 | 7.4% | -5.1 points |
| Q4 2024 | 12% | +7 points |
| Q3 2024 | 15% | +15 points |
SRAD's operating margin was 10% last quarter, up 1.5 points from the same quarter a year ago.
NVDA Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $21.4B | +59% |
| Q2 2026 | $48.6B | +86% |
| Q1 2026 | $34.9B | +124% |
| Q4 2025 | $22.1B | +32% |
| Q3 2025 | $13.5B | -0.3% |
| Q2 2025 | $26.2B | +75% |
| Q1 2025 | $15.6B | +38% |
| Q3 2024 | $13.5B | +113% |
NVDA has the edge over SRAD on cash flow, with more consistent year-over-year improvement.
SRAD Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | $127.2M | +112% |
| Q1 2026 | $51.1M | +36% |
| Q4 2025 | $21.8M | +$24.3M |
| Q3 2025 | $126.7M | +78% |
| Q2 2025 | $60.1M | -12% |
| Q1 2025 | $37.7M | +1626% |
| Q4 2024 | -$2.5M | -185% |
| Q3 2024 | $71M | +178% |
SRAD generated $327M in free cash flow over the past year, up 96% from the year before.
NVDA Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.4% | -106M shares |
| 1 year | -1% | -247M shares |
| 3 years | -2.8% | -705M shares |
| 5 years | -4.1% | -1B shares |
| Available history | -1.8% | -435M shares |
NVDA has 24.3B diluted shares, down 1% from a year ago, with $55.3B in buybacks over the past year.
| Quarter | Spent |
|---|---|
| Q3 2026 | $19.7B |
| Q2 2026 | $19.3B |
| Q1 2026 | $3.8B |
| Q4 2025 | $12.5B |
| Q3 2025 | $9.7B |
| Q2 2025 | $14.1B |
| Q1 2025 | $7.8B |
| Q4 2024 | $11B |
NVDA spent $55.3B buying back its own shares over the past year, up 30% from the year before.
SRAD Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -1.4% | -4.2M shares |
| 1 year | -8.3% | -26.5M shares |
| 3 years | -5.3% | -16.5M shares |
| 5 years | -0.8% | -2.3M shares |
| Available history | -0.8% | -2.4M shares |
SRAD has the edge over NVDA on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q2 2026 | $141.3M |
| Q1 2026 | $101.6M |
| Q4 2025 | $26.7M |
| Q3 2025 | $2.2M |
| Q2 2025 | $69.5M |
| Q1 2025 | $18.5M |
| Q4 2024 | $9.9M |
| Q3 2024 | $8.7M |
SRAD spent $272M buying back its own shares over the past year, up 155% from the year before.
NVDA Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.1x | Very low |
| Q2 2026 | -0.0x | Net Cash |
| Q1 2026 | -0.0x | Net Cash |
| Q4 2025 | -0.0x | Net Cash |
| Q3 2025 | -0.0x | Net Cash |
| Q2 2025 | -0.1x | Net Cash |
| Q1 2025 | -0.0x | Very low |
| Q4 2024 | -0.0x | Net Cash |
NVDA's net debt is less than a year of its operating earnings (EBITDA), after holding more cash than debt a year ago.
SRAD Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q2 2026 | -0.4x | Net Cash |
| Q1 2026 | -0.5x | Net Cash |
| Q4 2025 | -0.6x | Net Cash |
| Q3 2025 | -0.6x | Net Cash |
| Q2 2025 | -0.5x | Net Cash |
| Q1 2025 | -0.7x | Net Cash |
| Q4 2024 | -0.7x | Net Cash |
| Q3 2024 | -0.8x | Net Cash |
SRAD has the edge over NVDA on leverage, with a lower net debt burden relative to earnings.
NVDA Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 33.4 | Neutral |
| Stochastic | 18.1 | Oversold |
NVDA's weekly RSI is 33 (neutral) and its Stochastic is 18 (oversold).
SRAD Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 45.1 | Neutral |
| Stochastic | 38.9 | Neutral |
SRAD's weekly RSI is 45 (neutral) and its Stochastic is 39 (neutral).
NVDA PE vs Technology Sector
| Metric | NVDA | Sector median | Relative |
|---|---|---|---|
| PE | 21x | 28x | 25% below |
| PE % | 0 | 35 | 35 pts below |
NVDA has the edge over SRAD on valuation relative to its sector.
SRAD PE vs Technology Sector
| Metric | SRAD | Sector median | Relative |
|---|---|---|---|
| PE | 231x | 28x | 728% above |
| PE % | 87 | 45 | 42 pts above |
SRAD is trading at 231x earnings, a 728% premium to the Technology sector's median of 28x, though its earnings don't support one.
NVDA Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $208.9 | 20% below |
| 20 week MA | $212.0 | 22% below |
| 50 week MA | $199.9 | 17% below |
| 100 week MA | $175.1 | 5.1% below |
| 200 week MA | $123.6 | 34% above |
NVDA has fallen below most of its moving averages, though it's still 34% above its 200-week average.
SRAD Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $12.5 | 3.4% above |
| 20 week MA | $13.2 | 2.3% below |
| 50 week MA | $15.7 | 18% below |
| 100 week MA | $20.1 | 36% below |
| 200 week MA | $15.9 | 19% below |
SRAD has bounced recently, but its long-term trend is still down: it's above its 8-week average, but 19% below its 200-week average.
NVDA Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $5.92 | $13.0 | +119% |
| 2021 | $13.0 | $29.6 | +128% |
| 2022 | $29.6 | $15.2 | -49% |
| 2023 | $15.2 | $49.5 | +226% |
| 2024 | $49.5 | $137.0 | +177% |
| 2025 | $137.0 | $190.5 | +39% |
| 2026 YTD | $190.5 | $166.2 | -13% |
NVDA has the edge over SRAD on returns for 2026, with the stronger performance.
SRAD Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2021 | $27.0 | $18.6 | -31% |
| 2022 | $18.6 | $9.44 | -49% |
| 2023 | $9.44 | $11.1 | +17% |
| 2024 | $11.1 | $17.4 | +58% |
| 2025 | $17.4 | $23.1 | +33% |
| 2026 YTD | $23.1 | $12.9 | -44% |
SRAD is down 44% so far in 2026, after finishing higher in three of the previous five years.